On Monday, Plexus earned a positive adjustment to its Relative Strength (RS) Rating, from 64 to 72.
Can You Really Time The Stock Market?
IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the trailing 52 weeks matched up against all other stocks.
Decades of market research shows that the best stocks typically have an RS Rating of at least 80 as they launch their biggest price moves. See if Plexus can continue to rebound and hit that benchmark.
Plexus is not currently near a potential buy zone. See if the stock goes on to form a sound pattern that could kick off a new price move.
Earnings growth fell last quarter from 41% to 39%. But sales moved higher, from -1% to 1%. Look for the next report on or around Jul. 23.
Plexus holds the No. 7 rank among its peers in the Electronics-Contract Manufacturing industry group. Celestica, Fabrinet and TTM Technologies are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
